Common use of Table A3 Clause in Contracts

Table A3. Distribution of patient results using each of the three screening methods with patients with unconfirmed negative results characterized as COVID-19 positive, n = 531 COVID 70 79 79 70 108 41 test positive COVID 104 278 138 244 61 321 test negative Comparison of performance of three different ED screening methods with patients with unconfirmed negative results characterized as COVID-19 positive, n = 531 Sensitivity Specificity PPV NPV NTS 0.47 (0.39-0.55) 0.73 (0.68-0.77) 0.40 (0.33-0.48) 0.78 (0.73-0.82) ▇▇ ▇▇▇ 0.53 (0.43-0.61) 0.64 (0.59-0.69) 0.36 (0.30-0.43) 0.78 (0.73-0.82) Attending physician PA 0.72 (0.65-0.79) 0.84 (0.80-0.87) 0.64 (0.56-0.71) 0.89 (0.85-0.92)